Radiochemotherapy in association with capecitabine and oxaliplatin in the treatment of pancreatic and biliary tract, unresectable cancer: a dose escalation study - XelOx -P07
- Conditions
- pancreatic and biliary tract, unresectable cancerMedDRA version: 9.1Level: LLTClassification code 10033611Term: Pancreatic carcinoma non-resectable
- Registration Number
- EUCTR2007-004814-15-IT
- Lead Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Histologically proved carcinoma of pancreas or biliary tract
measurable disease
age >18 years
performance status (ECOG) 0-1
no previous chemio or radiotherapeutic treatments
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
metastasis
previous radiotherapy or chemiotherapy
renal failure
hepatic failure
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method